BIOGEN INC.

13D and 13G Filings

13D/G filings
13D on 2 securities
CIK
0000875045
All SEC filings
View on sec.gov
Issuer % of Class Filed
Apellis Pharmaceuticals, Inc. 13D/A Amendment 1
APLS · 03753U106
0% 5/14/2026
Event 5/14/2026
Apellis Pharmaceuticals, Inc. 13D
APLS · 03753U106
14.2% 4/6/2026
Event 3/31/2026
Sage Therapeutics, Inc. 13D/A Amendment 2
SAGE · 78667J108
0% 7/30/2025
Event 7/30/2025
Sage Therapeutics, Inc. 13D/A Amendment 1
SAGE · 78667J108
10.0% 7/21/2025
Event 7/21/2025
Sage Therapeutics, Inc. 13D
SAGE · 78667J108
10.2% 1/10/2025
Event 1/10/2025

Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.